# Retrospective Study With Patients Treated With STALIF® C or M and Ti or FLX Implants for 1 and 2 Levels

> **NCT05610397** · — · UNKNOWN · sponsor: **Centinel Spine** · enrollment: 200 (estimated)

## Conditions studied

- Degenerative Disc Disease
- Grade 1 Spondylolisthesis
- Retrolisthesis
- Symptomatic Cervical Disc Disease

## Interventions

- **DEVICE:** STALIF®

## Key facts

- **NCT ID:** NCT05610397
- **Lead sponsor:** Centinel Spine
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-24
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-09
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2023-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05610397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05610397, "Retrospective Study With Patients Treated With STALIF® C or M and Ti or FLX Implants for 1 and 2 Levels". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05610397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
